RT Journal Article
SR Electronic
T1 Timeline of SARS-CoV2 spread in Italy: results from an independent serological retesting
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.14.21260491
DO 10.1101/2021.07.14.21260491
A1 Montomoli, Emanuele
A1 Apolone, Giovanni
A1 Manenti, Alessandro
A1 Boeri, Mattia
A1 Suatoni, Paola
A1 Sabia, Federica
A1 Marchianò, Alfonso
A1 Bollati, Valentina
A1 Pastorino, Ugo
A1 Sozzi, Gabriella
YR 2021
UL http://medrxiv.org/content/early/2021/07/19/2021.07.14.21260491.abstract
AB The massive emergence of COVID19 cases in the first phase of pandemic within an extremely short period of time suggest that an undetected earlier circulation of SARS-CoV-2 might have occurred, as documented by several papers in different countries, including a few that reported positive cases even earlier the first cases identified in Wuhan. Given the importance of this evidence, an independent evaluation was recommended. Here we report the results of SARS-CoV-2 antibodies blind retesting of blood samples collected in the prepandemic period in Italy, and in control samples collected one year before, by two independent centers. Results suggest the presence of SARS-CoV-2 antibodies in some samples collected in the prepandemic period, though the detection of IgM and/or IgG binding and neutralizing antibodies is strongly dependent on the different serological assays and thresholds employed, while being absent in control samples collected one year before. These findings highlight the importance of harmonizing serological assays for testing SARS-CoV-2 virus spreading and may contribute to a better understanding the future virus dynamics.Article Summary Line We report the results of an independent retesting of SARS-CoV-2 antibodies in blood samples collected in prepandemic period in Italy and in matched samples collected one year before. The findings indicate the presence of IgM and/or IgG antibodies in selected samples of the prepandemic period only with different performance of serological assays used by the two centers. The results could give highlights on SARS-CoV-2 circulation in the pre-pandemic period and contribute to better predict future virus dynamic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board and Ethics Committee of Fondazione IRCCS Istituto Nazionale dei Tumori of Milan approved the study. All eligible subjects provided written informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available upon request to the corresponding author.